Laurion Capital Management LP - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 2 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Laurion Capital Management LP ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$126,076
-69.3%
11,287
+38.0%
0.00%
-80.0%
Q2 2020$411,000
+9.0%
8,178
+34.1%
0.01%
+66.7%
Q4 2019$377,0006,1000.00%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 1,055,719$35,367,00012.68%
GREAT POINT PARTNERS LLC 828,253$27,746,0005.70%
McClain Value Management LLC 116,153$3,891,0004.80%
Stonepine Capital Management, LLC 231,913$7,769,0004.63%
ARMISTICE CAPITAL, LLC 228,000$7,638,0001.81%
Opaleye Management Inc. 90,000$3,015,0001.78%
Matarin Capital Management, LLC 257,268$8,618,478,0000.97%
HAYS ADVISORY LLC 116,939$3,917,0000.87%
Granahan Investment Management 496,025$16,617,0000.57%
AlphaMark Advisors, LLC 33,000$1,106,0000.57%
View complete list of ENANTA PHARMACEUTICALS INC shareholders